| Changes in the Management of Renal Anemia Reported by Nephrologists Are ... - PharmiWeb.com (press release) |
|
|
PharmiWeb.com (press release) US Nephrologists have started reporting changes in the use of erythropoietin stimulating agents (ESAs) and intravenous (IV) iron in the management of renal anemia in dialysis patients due to the new dialysis bundled payment system, and the recently |